Journal article
The impact project: Improving the impact of existing malaria products – Acts
- Abstract:
-
The antimalarial dihydroartemisinin-piperaquine (DHA-PPQ) is one of the recommended drugs to treat uncomplicated Plasmodium falciparum malaria. However, DHA-PPQ has a relatively narrow, poorly defined therapeutic dose range and it is unclear whether PPQ concentration-dependent cardiotoxicity (QTc prolongation) poses a clinical risk for specific subgroups. Uncertainty about the exact safe upper PPQ concentration threshold and recognition of the vulnerability of children has led WHO to consider...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 58.4KB)
-
- Publisher copy:
- 10.1136/bmjgh-2016-000260.66
Authors
Bibliographic Details
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- BMJ Global Health Journal website
- Volume:
- 2
- Issue:
- Suppl 2
- Pages:
- A26.1-A26
- Publication date:
- 2017-02-01
- Acceptance date:
- 2016-08-15
- DOI:
- ISSN:
-
2059-7908
- Source identifiers:
-
745818
Item Description
- Pubs id:
-
pubs:745818
- UUID:
-
uuid:99370a1b-da52-4151-98b2-d8557720fd8b
- Local pid:
- pubs:745818
- Deposit date:
- 2018-01-25
Terms of use
- Copyright holder:
- Humphreys et al
- Copyright date:
- 2017
- Notes:
-
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
If you are the owner of this record, you can report an update to it here: Report update to this record